From the *Departamento de Pediatría, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia

†División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia

‡Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia

§Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.

Accepted for publication May 9, 2023

Supported by Ministerio de Ciencia Tecnología e Innovación, grant 112451929026 (D.M.S.) and the Sistema General de Regalías del Departamento del Huila (S.G.R.), project BPIN 2020000100145 (C.F.N.) and Vicerrectoría de Investigación y Proyección Social, Universidad Surcolombiana (C.F.N.). The other authors have no conflicts of interest to disclose.

The researchers actively participated in the study design, patient’s enrollment, data collection, measurement of circulating cytokines, analysis of results and writing of the article. All authors approved the final version of the article.

This study was approved by the ethics committee of Hospital Universitario de Neiva (approval code No. 030-2010).

All relevant data are within the article and its supporting information files.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).

Address for correspondence: Carlos F. Narváez, MD, PhD, División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia. Calle 9 No 14—03, Altico, Neiva, Huila, Colombia. E-mail: [email protected].